About Us

Publications

BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: Some Publications were unable to be listed below - please see that listing here. All other publications based on PubMedIDs are listed below.

 

Found 2 results
Filters: Author is Panoskaltsis-Mortari, A  [Clear All Filters]
2018
L. M. Turcotte, DeFor, T. E., Newell, L. F., Cutler, C. S., Verneris, M. R., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Vercellotti, G. M., Slungaard, A., Blazar, B. R., Weisdorf, D. J., Panoskaltsis-Mortari, A., and Holtan, S. G., “Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.”, Bone Marrow Transplant, vol. 53, no. 1, pp. 64-68, 2018.
2017
S. G. Holtan, Newell, L. F., Cutler, C., Verneris, M. R., DeFor, T. E., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Blazar, B. R., Weisdorf, D. J., and Panoskaltsis-Mortari, A., “Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402.”, Bone Marrow Transplant, vol. 52, no. 9, pp. 1300-1303, 2017.